🇺🇸 FDA
Patent

US 7745388

Peptides for activation and inhibition of δPKC

granted A61KA61K38/00A61P

Quick answer

US patent 7745388 (Peptides for activation and inhibition of δPKC) held by The United States of America as represented by NIH Division of Extramural Inventions and Technology Resources (DEITR) expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by NIH Division of Extramural Inventions and Technology Resources (DEITR)
Grant date
Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61P, A61P13/12, A61P25/00